-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Inhibrx Biosciences, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate for Q2 2024.
- Inhibrx Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending May 30, 2024 was $1.8M.
Share-based Payment Arrangement, Expense, Quarterly (USD)